Efficacy and Safety of Stiripentol on Dravet Syndrome: A Mini- Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
This mini-meta-analysis of two randomized, double-blind, placebo-controlled trials demonstrates that adjunctive stiripentol significantly reduces clonic and generalized tonic-clonic seizure frequency in patients with Dravet syndrome while maintaining a favorable safety and tolerability profile.